The Journal
Unlocking theaesthetics arena.
The studies that move the field. The regulation you’ll need to act on. The claims that don’t survive scrutiny. Concise, referenced, written for working clinicians.
Earlier pieces
Business
10 June 2026
Aesthetics Business Income in the UK: What Practitioners Are Actually Earning in 2026
Most aesthetic practitioners are earning less than their skills and training should command. The income gap is structural, not clinical. Here is what it looks like and how practitioners are closing it.
Clinical
10 June 2026
The Acne Microbiome: What UK Aesthetic Practitioners Need to Know
Acne is not a single-organism disease. Understanding microbial diversity, strain differences, and treatment interactions changes how you approach acne assessment in aesthetic practice.
Ingredient science
9 June 2026
Topical Peptides in Aesthetic Practice: What the Evidence Shows
Topical peptides are among the most evidence-referenced ingredients in aesthetic skincare. What the clinical evidence shows, and what practitioners need to assess.
Ingredient science
4 June 2026
Topical Vitamin C in Aesthetics: What the Evidence Shows
Topical vitamin C has more peer-reviewed evidence behind it than most active ingredients in aesthetic skincare. Here is what the literature actually supports.
Regulation
4 June 2026
What aesthetic practitioners in England need to have done before July 2026
The licensing deadline is weeks away. This is the practical checklist: what documentation you need, what gaps are most commonly found, and where to start if you haven't started.
Ingredient science
3 June 2026
Tranexamic Acid for Melasma: The 2026 Evidence Review
Tranexamic acid for melasma has the strongest evidence base of any oral depigmenting option. What the meta-analyses show, and what UK practitioners must know.
Regulation
3 June 2026
Exosomes in Aesthetics: What the Evidence and Regulators Say
Exosomes are the most-marketed product in aesthetics right now. What the clinical evidence actually supports, and where UK and FDA regulators draw the line.
Treatments
28 May 2026
Glycolic Acid Peels in UK Aesthetic Practice: The Evidence
Glycolic acid peels are among the best-evidenced superficial procedures in UK aesthetic practice. What the evidence shows for acne, PIH, and photoaging.
Ingredient science
26 May 2026
Topical Vitamin C in Aesthetic Practice: The Clinical Evidence
Topical vitamin C is among the best-evidenced cosmeceuticals in UK aesthetic practice. What peer-reviewed literature supports, and where formulation makes the difference.
Regulation
24 May 2026
NMC Prescribing Standards for Cosmetic Injectables 2025
From June 2025, NMC registrants must consult face-to-face before prescribing cosmetic injectables. Here is what changed and what compliance requires.
Ingredient science
21 May 2026
Retinoids in UK Aesthetic Practice: The Clinical Evidence
Topical retinoids in UK aesthetic practice: what the peer-reviewed evidence supports, where the prescribing boundary sits, and how to apply them clinically.
Ingredient science
14 May 2026
Niacinamide in Aesthetic Practice: The Clinical Evidence
Niacinamide is among the most-discussed actives in UK clinics. What the peer-reviewed evidence supports across hyperpigmentation, acne, and barrier repair.
Treatments
12 May 2026
Rosacea Treatment in Aesthetic Practice: 2026 Evidence
Rosacea treatment for UK aesthetic practitioners: what each subtype responds to, where the evidence base sits, and where scope of practice begins and ends.
Ingredient science
10 May 2026
Azelaic Acid for UK Practitioners: The Full Clinical Picture
Azelaic acid is licensed for rosacea and acne in the UK. Here is what the evidence supports across all three indications and what practitioners need to know.
Ingredient science
3 May 2026
PIH vs PIE: why your acne client's marks aren't fading
If your acne client's marks aren't fading after the spots clear, the issue isn't acne anymore. It's whether you're treating PIH or PIE.
Regulation
2 May 2026
England's aesthetic licensing scheme: what's coming, and how to be ready before it lands
England's statutory licensing scheme for non-surgical cosmetic procedures is the biggest regulatory shift UK aesthetics has seen. Here is what the legislation says, what the consultation has signalled, and what practitioners should be doing now.
Treatments
30 April 2026
Vascular Occlusion in Hyaluronic Acid Filler: UK Practitioner Protocol
Vascular occlusion hyaluronic acid filler UK: recognition, hyaluronidase protocol, prescribing duties and the documentation a defensible practitioner needs.
Ingredient science
30 April 2026
Polynucleotides in 2026: what the evidence supports, and what the marketing has run ahead of
Polynucleotides are the most-asked-about ingredient in UK clinics this year. Here is what the published evidence supports, where it is thinner than the marketing claims, and how to talk about it without overpromising.
Studies
30 April 2026
NICE Acne Guidelines (NG198) for Aesthetic Practitioners
NICE acne guidelines NG198: severity bands, first-line treatments, referral pathways, and what aesthetic practitioners can and can't do under the framework.
Regulation
30 April 2026
MHRA Rules on Promoting Botox in the UK: What Practitioners Can Say
MHRA Botox advertising UK: the POM advertising prohibition, the MHRA Blue Guide, the CAP Code, and what a UK practitioner can actually put online.
Treatments
28 April 2026
Vascular occlusion: the recognition window every injector needs to own
Vascular occlusion is the complication every injector trains for and hopes never to see. When it happens, the first ninety minutes decide whether the client keeps her tissue.
Regulation
28 April 2026
UK Aesthetics Licensing Scheme 2026: Where It Stands
The UK aesthetics licensing scheme: what's in scope, what's next, and what working practitioners need on the record before it lands.
Ingredient science
28 April 2026
Polynucleotides in UK Aesthetic Practice: The 2026 Evidence Read
Polynucleotides in UK aesthetic practice, what the peer-reviewed evidence actually supports in 2026, and where the limits sit.
Treatments
28 April 2026
Microneedling Evidence in 2026: What UK Practitioners Should Know
Microneedling in 2026: where the peer-reviewed evidence actually sits, where it is still thin, and what UK practitioners need to know.
Editorial
27 April 2026
Why this exists. What you'll get from it.
The studies that matter. The regulation that's changing. The claims that don't survive a primary source, for working clinicians.